EUR/USD continues to test downtrend

In Europe, manufacturing data showed some positive signs and Germany is looking particularly strong.

EUR
Source: Bloomberg

EUR/USD remains quite resilient and there is a bit of optimism on the Greek front as well, which is giving the single currency a bit of a tailwind. While EUR/USD has remained resilient this week, it’s still just flirting with a downtrend resistance line that has been in place since December last year.

Until we see a close above $1.1000, I wouldn’t be jumping into longs just yet as the medium-term trend is still lower. On the calendar today we have the German Ifo business climate reading, which is also likely to show positive signs. Whether this can keep the euro’s run going will be questionable.

In the US, we have the February durable goods orders, which could resuscitate the greenback if the data beats expectations. Failure to close above $1.1000 could be a trigger for renewed EUR/USD shorts.

Click to enlarge

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.